CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Over-The-Counter Monograph Drug User Fee Program (OMUFA)

RegulatoryNeutral
AI Analysis

Summary

The FDA is considering a user fee program for over-the-counter monograph drugs as a potential funding mechanism to supplement congressional appropriations.

Importance:2/10
Sentiment:
0.00
OTCmonographuser feeregulatory
Related Companies

Read the original article

Published by FDA Drugs (New Approvals & NDA) on July 7, 2026 5:03 PM

Read Original